Who is Philip T Gianos?
Philip T Gianos has an estimated net worth of $399 Million. This is based on reported shares across multiple companies, which include TESARO, Inc., EnteroMedics Inc, ANESIVA, INC., INTRALASE CORP, Invuity, Inc., Trius Therapeutics Inc, XILINX INC, T/R SYSTEMS INC, GLAUKOS Corp, MACROGENICS INC, Eiger BioPharmaceuticals, Inc., Carbylan Therapeutics, Inc., Marketo, Inc., OBALON THERAPEUTICS INC, Restoration Robotics Inc, APPLIED GENETIC TECHNOLOGIES CORP, Transcept Pharmaceuticals Inc, EPOCRATES INC, MYOGEN INC, and METABASIS THERAPEUTICS INC.
Philip T Gianos's CIK is 0001207831
Past Insider Trading and Trends
2014 was Philip T Gianos's most active year for acquiring shares with 42 total transactions. Philip T Gianos's most active month to acquire stocks was the month of July. 2014 was Philip T Gianos's most active year for disposing of shares, totalling 41 transactions. Philip T Gianos's most active month to dispose stocks was the month of September. 2007 saw Philip T Gianos paying a total of $9,517,814.05 for 3,536,070 shares, this is the most they've acquired in one year. In 2013 Philip T Gianos cashed out on 40,805,378 shares for a total of $71,280,119.84, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!